| Year |
Citation |
Score |
| 2012 |
Broussard GJ, Mytar J, Li RC, Klapstein GJ. The role of inflammatory processes in Alzheimer's disease. Inflammopharmacology. 20: 109-26. PMID 22535513 DOI: 10.1007/s10787-012-0130-z |
0.654 |
|
| 2005 |
Cepeda C, André VM, Flores-Hernández J, Nguyen OK, Wu N, Klapstein GJ, Nguyen S, Koh S, Vinters HV, Levine MS, Mathern GW. Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Developmental Neuroscience. 27: 59-76. PMID 15886485 DOI: 10.1159/000084533 |
0.722 |
|
| 2005 |
Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS. Striatal potassium channel dysfunction in Huntington's disease transgenic mice. Journal of Neurophysiology. 93: 2565-74. PMID 15625098 DOI: 10.1152/Jn.00791.2004 |
0.679 |
|
| 2005 |
Klapstein GJ, Levine MS. Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice. Journal of Neurophysiology. 93: 758-65. PMID 15371492 DOI: 10.1152/Jn.00483.2004 |
0.458 |
|
| 2003 |
Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. The Journal of Biological Chemistry. 278: 43628-35. PMID 12930822 DOI: 10.1074/Jbc.M308947200 |
0.545 |
|
| 2003 |
Cepeda C, Hurst RS, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Boylan MK, Calvert CR, Jocoy EL, Nguyen OK, André VM, Vinters HV, Ariano MA, Levine MS, Mathern GW. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. Journal of Neuroscience Research. 72: 472-86. PMID 12704809 DOI: 10.1002/Jnr.10604 |
0.649 |
|
| 2001 |
Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. Journal of Neurophysiology. 86: 2667-77. PMID 11731527 DOI: 10.1152/Jn.2001.86.6.2667 |
0.576 |
|
| 2001 |
Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9112-23. PMID 11717344 DOI: 10.1523/Jneurosci.21-23-09112.2001 |
0.569 |
|
| 1999 |
Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet MF. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58: 515-32. PMID 10533044 DOI: 10.1002/(Sici)1097-4547(19991115)58:4<515::Aid-Jnr5>3.0.Co;2-F |
0.525 |
|
| 1999 |
Klapstein GJ, Meldrum BS, Mody I. Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling. Neuropharmacology. 38: 927-33. PMID 10428411 DOI: 10.1016/S0028-3908(99)00016-7 |
0.534 |
|
| 1999 |
Colmers WF, Klapstein GJ, Rory McQuiston A, Ho MWY. Sites and mechanisms of NPY anticonvulsant actions in vitro Italian Journal of Neurological Sciences. 20: 197. |
0.531 |
|
| 1998 |
Klapstein GJ, Vietla S, Lieberman DN, Gray PA, Airaksinen MS, Thoenen H, Meyer M, Mody I. Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: evidence from calbindin-D28k knockout mice. Neuroscience. 85: 361-73. PMID 9622236 DOI: 10.1016/S0306-4522(97)00632-5 |
0.642 |
|
| 1998 |
Klapstein GJ, Vietla S, Lieberman DN, Gray PA, Airaksinen MS, Thoenen H, Meyer M, Mody I. Calbindin-D(28k) falls to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: Evidence from calbindin-D(28k) knockout mice Neuroscience. 85: 361-373. DOI: 10.1016/S0306-4522(97)00632-5 |
0.521 |
|
| 1997 |
Klapstein GJ, Colmers WF. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. Journal of Neurophysiology. 78: 1651-61. PMID 9310450 DOI: 10.1152/Jn.1997.78.3.1651 |
0.644 |
|
| 1993 |
Klapstein GJ, Colmers WF. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus. 3: 103-11. PMID 8395947 DOI: 10.1002/hipo.450030111 |
0.637 |
|
| 1992 |
Klapstein GJ, Colmers WF. 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. British Journal of Pharmacology. 105: 470-4. PMID 1313731 DOI: 10.1111/J.1476-5381.1992.Tb14277.X |
0.605 |
|
| 1991 |
Colmers WF, Klapstein GJ, Fournier A, St-Pierre S, Treherne KA. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. British Journal of Pharmacology. 102: 41-4. PMID 1646061 DOI: 10.1111/J.1476-5381.1991.Tb12129.X |
0.638 |
|
| 1990 |
Klapstein GJ, Treherne KA, Colmers WF. Neuropeptide Y presynaptic effects in hippocampal slice in vitro are Y2 receptor mediated but not via inhibition of adenylate cyclase Annals of the New York Academy of Sciences. 611: 457-458. DOI: 10.1111/J.1749-6632.1990.Tb48983.X |
0.582 |
|
| Show low-probability matches. |